The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The Antifolates
Open accessAbstract
This article focuses on the cellular, biochemical, and molecular pharmacology of antifolates and how a basic understanding of the mechanism of action of methotrexate, its cytotoxic determinants, mechanisms of resistance, and transport into and out of cells has led to the development of a new generation of antifolates, a process that continues in the laboratory and in the clinics. New approaches to folate-based cancer chemotherapy are described based on the targeted delivery of drugs to malignant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.163 · Cited by 2,426
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2472 · Cited by 1,545
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Ciuleanu, T., Brodowicz, T., Zielinski, C., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y.-L., Bover, I., Begbie, S., Tzekova, V., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61497-5 · Cited by 1,111
Qiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., & Goldman, I. D. (2006) · Cell · doi:10.1016/j.cell.2006.09.041 · Cited by 847
Self-citationUnderstanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730
Salliot, C., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093690 · Cited by 673
The MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 614
Shih, C., Chen, V. J., Gossett, L. S., Gates, S. B., MacKellar, W. C., Habeck, L. L., Shackelford, K. A., Mendelsohn, L. G., Soose, D. J., Patel, V. F., et al. (1997) · PubMed · Cited by 560
Folate-targeted therapies for cancer
Xia, W., & Low, P. S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100509v · Cited by 448
Zhao, R., Matherly, L. H., & Goldman, I. D. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000969 · Cited by 392
Self-citationPuig-Kröger, A., Sierra-Filardi, E., Domínguez-Soto, A., Samaniego, R., Corcuera, M. T., Gómez-Aguado, F., Ratnam, M., Sánchez-Mateos, P., & Corbí, A. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2050 · Cited by 389
Gennari, A., Sormani, M. P., Pronzato, P., Puntoni, M., Colozza, M., Pfeffer, U., & Bruzzi, P. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm252 · Cited by 371
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Kalb, R. E., Strober, B., Weinstein, G., & Lebwohl, M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.906 · Cited by 368
Mechanisms of Membrane Transport of Folates into Cells and Across Epithelia
Zhao, R., Diop-Bove, N., Visentin, M., & Goldman, I. D. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145133 · Cited by 365
Self-citationJackman, A. L., Taylor, G. A., Gibson, W., Kimbell, R., Brown, M., Calvert, H., Judson, I. R., & Lr, H. (1991) · PubMed · Cited by 357
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.
Allegra, C. J., Chabner, B. A., Drake, J. C., Lutz, R., Rodbard, D., & Jolivet, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39298-0 · Cited by 335
Folylpolyglutamate Synthesis and Role in the Regulation of One-Carbon Metabolism
Shane, B. (1989) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60397-0 · Cited by 322
Allegra, C. J., Drake, J. C., Jolivet, J., & Chabner, B. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4881 · Cited by 310
Gaynon, P. S., Angiolillo, A. L., Carroll, W. L., Nachman, J. B., Trigg, M. E., Sather, H. N., Hunger, S. P., Devidas, M., & for the Children's Oncology Group, A. C. (2010) · Leukemia · doi:10.1038/leu.2009.262 · Cited by 293
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications
Chattopadhyay, S., Moran, R. G., & Goldman, I. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0343 · Cited by 281
Self-citationHuman reduced folate carrier: translation of basic biology to cancer etiology and therapy
Matherly, L. H., Hou, Z., & Deng, Y. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9046-2 · Cited by 275
Folic acid metabolism in health and disease
Price, J. (1991) · Trends in Food Science & Technology · doi:10.1016/0924-2244(91)90712-r · Cited by 269
Kamen, B. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.002 · Cited by 264
Taylor, E. C., Kuhnt, D., Shih, C., Rinzel, S. M., Grindey, G. B., Barredo, J., Jannatipour, M., & Moran, R. G. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a023 · Cited by 254
Zhao, R., & Goldman, I. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206946 · Cited by 253
Self-citationOsteosarcoma: Review of the Past, Impact on the Future. The American Experience
Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_12 · Cited by 252
Scagliotti, G. V., Shin, D.-M., Kindler, H. L., Vasconcelles, M. J., Keppler, U., Manegold, C., Burris, H., Gatzemeier, U., Blatter, J., Symanowski, J. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.122 · Cited by 251
Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy
Niyikiza, C., Baker, S. D., Seitz, D. E., Walling, J. M., Nelson, K., Rusthoven, J. J., Stabler, S. P., Paoletti, P., Calvert, A. H., & Allen, R. H. (2002) · PubMed · doi:10.25405/ncl.34649535 · Cited by 248
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Assaraf, Y. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.09.001 · Cited by 235
Hryniuk, W. M., & Bertino, J. R. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106181 · Cited by 228
Enzymatic Transition States, Transition-State Analogs, Dynamics, Thermodynamics, and Lifetimes
Schramm, V. L. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061809-100742 · Cited by 225
Cocconi, G., Cunningham, D., Van Cutsem, E., Francois, E., Gustavsson, B., van Hazel, G., Kerr, D., Possinger, K., & Hietschold, S. M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2943 · Cited by 216
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Baggott, J. E., Vaughn, W. H., & Hudson, B. B. (1986) · Biochemical Journal · doi:10.1042/bj2360193 · Cited by 205
O'Connor, O. A., Horwitz, S., Hamlin, P., Portlock, C., Moskowitz, C. H., Sarasohn, D., Neylon, E., Mastrella, J., Hamelers, R., MacGregor-Cortelli, B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8470 · Cited by 187
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Asselin, B. L., Devidas, M., Wang, C., Pullen, J., Borowitz, M. J., Hutchison, R., Lipshultz, S. E., & Camitta, B. M. (2011) · Blood · doi:10.1182/blood-2010-06-292615 · Cited by 172
ANCA-associated vasculitides—advances in pathogenesis and treatment
Chen, M., & Kallenberg, C. G. M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.158 · Cited by 159
Zhao, R., Min, S. H., Qiu, A., Sakaris, A., Goldberg, G. L., Sandoval, C., Malatack, J. J., Rosenblatt, D. S., & Goldman, I. D. (2007) · Blood · doi:10.1182/blood-2007-02-077099 · Cited by 156
Self-citationRacanelli, A. C., Rothbart, S. B., Heyer, C. L., & Moran, R. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4979 · Cited by 149
Matloub, Y., Bostrom, B., Hunger, S. P., Stork, L. C., Angiolillo, A. L., Sather, H. N., La, M., Gastier, J. M., Heerema, N. A., Sailer, S. L., et al. (2011) · Blood · doi:10.1182/blood-2010-12-322909 · Cited by 148
Colleoni, M. A., Cole, B. F., Viale, G., Regan, M. M., Price, K. N., Maiorano, E., Mastropasqua, M. G., Crivellari, D., Gelber, R. D., Goldhirsch, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9549 · Cited by 143
Fisher, R. E., Siegel, B. A., Edell, S. L., Oyesiku, N. M., Morgenstern, D. E., Messmann, R. A., & Amato, R. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049478 · Cited by 143
Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
Skipper, H. E., & Perry, S. (1970) · PubMed · Cited by 140
Allegra, C. J., Fine, R. L., Drake, J. C., & Chabner, B. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84587-8 · Cited by 137
Zhao, R., Qiu, A., Tsai, E., Jansen, M., Akabas, M. H., & Goldman, I. D. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045443 · Cited by 129
Self-citationMetabolic consequences of a reversed pH gradient in rat tumors.
Stubbs, M., Rodrigues, L. M., Howe, F. A., Wang, J., Jeong, K.-S., Veech, R. L., & Griffiths, J. R. (1994) · PubMed · Cited by 127
Wang, E. S., O’Connor, O. A., She, Y., Zelenetz, A. D., Sirotnak, F. M., & Moore, M. A. S. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000077124 · Cited by 116
Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy, J. A., Xu, L.-C., Parker, N. L., Vetzel, M., & Leamon, C. P. (2004) · PubMed · Cited by 113
Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug Conjugate
Leamon, C. P., Reddy, J. A., Vlahov, I. R., Westrick, E. M., Dawson, A., Dorton, R., Vetzel, M., Santhapuram, H. K. R., & Wang, Y. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070049c · Cited by 109
Gibbs, D. D., Theti, D. S., Wood, N., Green, M., Raynaud, F. I., Valenti, M. R., Forster, M. D., Mitchell, F., Bavetsias, V., Henderson, E. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2034 · Cited by 101
Advances in the pathogenesis and treatment of IBD
Braus, N. A., & Elliott, D. E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.02.006 · Cited by 100
Chapter 5 Structure and Function of the Reduced Folate Carrier
Matherly, L. H., & Hou, Z. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00405-6 · Cited by 96
A Prominent Low-pH Methotrexate Transport Activity in Human Solid Tumors
Zhao, R., Gao, F., Hanscom, M., & Goldman, I. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1066-03 · Cited by 95
Self-citationPemetrexed Indirectly Activates the Metabolic Kinase AMPK in Human Carcinomas
Rothbart, S. B., Racanelli, A. C., & Moran, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1873 · Cited by 90
Hanauske, A.-R., Eismann, U., Oberschmidt, O., Pospisil, H., Hoffmann, S., Hanauske-Abel, H. M., Ma, D., Chen, V., Paoletti, P., & Niyikiza, C. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9060-9 · Cited by 85
Li, J., Sausville, E. A., Klein, P., Morgenstern, D. E., Leamon, C. P., Messmann, R. A., & LoRusso, P. M. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009339740 · Cited by 80
Lowe, K. E., Osborne, C., Lin, B., Kim, J. S., Hsu, J. C., & Shane, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80593-6 · Cited by 78
Wang, Y., Zhao, R., & Goldman, I. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0645 · Cited by 73
Self-citationWang, L., Desmoulin, S. K., Cherian, C., Polin, L., White, K., Kushner, J., Fulterer, A., Chang, M., Mitchell-Ryan, S. K., Stout, M. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200739e · Cited by 72
Chapter 7 Exploitation of the Folate Receptor in the Management of Cancer and Inflammatory Disease
Leamon, C. P., & Jackman, A. L. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00407-x · Cited by 72
Djerassi, I. (1967) · PubMed · Cited by 69
Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin
DeGraw, J. I., Colwell, W. T., Piper, J. R., & Sirotnak, F. M. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00067a020 · Cited by 69
Habeck, L. L., Mendelsohn, L. G., Shih, C., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10251-4 · Cited by 66
Desmoulin, S. K., Wang, L., Hales, E. C., Polin, L., White, K., Kushner, J., Stout, M. L., Hou, Z., Cherian, C., Gangjee, A., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073833 · Cited by 62
Goldman, I. D., Chattopadhyay, S., Zhao, R., & Moran, R. G. (2010) · PubMed · Cited by 62
Self-citationPhase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Krug, L. M., Ng, K., Kris, M. G., Miller, V. A., Tong, W. P., Heelan, R. T., León, L. F., Leung, D. H. Y., Kelly, J., Grant, S. C., et al. (2000) · PubMed · Cited by 60
Chamberlain, M. C. (2010) · Seminars in Neurology · doi:10.1055/s-0030-1255220 · Cited by 57
Zhao, R., Hanscom, M., Chattopadhyay, S., & Goldman, I. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3953 · Cited by 56
Self-citationDosio, F., Milla, P., & Cattel, L. (2010) · PubMed · Cited by 54
Popov, I., Carrato, A., Sobrero, A. F., Vincent, M. D., Kerr, D. J., Labianca, R., Bianco, A. R., El-Serafi, M., Bedenne, L., Paillot, B., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.002 · Cited by 46
Pratt, C. B., Roberts, D., Shanks, E., & Warmath, E. L. (1974) · PubMed · Cited by 45
Establishment of pemetrexed-resistant non-small cell lung cancer cell lines
Zhang, D., Ochi, N., Takigawa, N., Tanimoto, Y., Chen, Y., Ichihara, E., Hotta, K., Tabata, M., Tanimoto, M., & Kiura, K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.006 · Cited by 44
Chattopadhyay, S., Zhao, R., Krupenko, S. A., Krupenko, N. I., & Goldman, I. D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0243 · Cited by 41
Self-citationChattopadhyay, S., Tamari, R., Min, S. H., Zhao, R., Tsai, E., & Goldman, I. D. (2007) · The Oncologist · doi:10.1634/theoncologist.12-7-808 · Cited by 37
Self-citationAccumulation of 5-methyltetrahydrofolate in cobalamin-deficient L1210 mouse leukemia cells.
Fujii, K., Nagasaki, T., & Huennekens, F. M. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34896-8 · Cited by 26
Schwartz, D. A., & Ferguson, J. R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x233241 · Cited by 12
Cited by
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
Sanderson, S. M., Gao, X., Dai, Z., & Locasale, J. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0187-8 · Cited by 563
Methotrexate mechanism in treatment of rheumatoid arthritis
Friedman, B., & Cronstein, B. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.004 · Cited by 439
Glucose Conjugation for the Specific Targeting and Treatment of Cancer
Calvaresi, E. C., & Hergenrother, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22205e · Cited by 398
Metadata
- Authors
- Visentin, M., Zhao, R., & Goldman, I. D.
- Venue
- Hematology/Oncology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 26
- Issue
- 3
- Pages
- 629-648
- ISSN
- 0889-8588 (ISSN-L)
- OpenAlex
- W4211141680
- Cited by
- 253
- References
- 84
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.